The Health Ministry warns that patients should take GLP-1 drugs for type 2 diabetes and obesity only under medical supervision due to potential severe health complications and side effects. The government is enforcing regulatory measures to prevent misuse and unauthorized sales.
from mint - science https://ift.tt/WAz4CZT
0 Comments